CLS looks forward to further expansion
Medtech company Clinical Laserthermia Systems has now joined the group of reporting companies. CEO Dan Mogren visited BioStock’s studio to summarise the most important events during Q3, with a particular focus on the urology and neurology segment. We also talked about the company’s finances and upcoming milestones.
See the interview with CLS‘ CEO Dan Mogren below.
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.
